Tower Research Capital (TRC)’s MiNK Therapeutics INKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-172
| Closed | -$1.49K | – | 5412 |
|
|
2025
Q1 | $1.49K | Sell |
172
-368
| -68% | -$3.18K | ﹤0.01% | 4699 |
|
|
2024
Q4 | $3.76K | Buy |
540
+137
| +34% | +$955 | ﹤0.01% | 4597 |
|
|
2024
Q3 | $3.02K | Sell |
403
-492
| -55% | -$3.69K | ﹤0.01% | 4907 |
|
|
2024
Q2 | $8.49K | Sell |
895
-211
| -19% | -$2K | ﹤0.01% | 4345 |
|
|
2024
Q1 | $10K | Buy |
1,106
+12
| +1% | +$109 | ﹤0.01% | 3760 |
|
|
2023
Q4 | $11.7K | Buy |
1,094
+324
| +42% | +$3.47K | ﹤0.01% | 4108 |
|
|
2023
Q3 | $8.46K | Sell |
770
-345
| -31% | -$3.79K | ﹤0.01% | 4344 |
|
|
2023
Q2 | $23.4K | Buy |
+1,115
| New | +$23.4K | ﹤0.01% | 3221 |
|
|
2022
Q3 | – | Sell |
-110
| Closed | -$2K | – | 6265 |
|
|
2022
Q2 | $2K | Sell |
110
-117
| -52% | -$2.13K | ﹤0.01% | 5551 |
|
|
2022
Q1 | $5K | Buy |
227
+44
| +24% | +$969 | ﹤0.01% | 5058 |
|
|
2021
Q4 | $8K | Buy |
+183
| New | +$8K | ﹤0.01% | 4792 |
|